Oral Antidiabetic Agents
Top Cited Papers
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 65 (3) , 385-411
- https://doi.org/10.2165/00003495-200565030-00005
Abstract
Type 2 diabetes mellitus is a progressive and complex disorder that is difficult to treat effectively in the long term. The majority of patients are overweight or obese at diagnosis and will be...Keywords
This publication has 63 references indexed in Scilit:
- Is There a Role for ??-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?Drugs, 2003
- Metabolic and Additional Vascular Effects of ThiazolidinedionesDrugs, 2002
- Cardiovascular risk reduction in diabetes: underemphasised and overdue. Messages from major trialsClinical Medicine, 2001
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Meglitinide Analogues in the Treatment of Type 2 Diabetes MellitusDrugs & Aging, 2000
- Antidiabetic Drugs Present and FutureDrugs, 2000
- ATP-sensitive K + channels and insulin secretion: their role in health and diseaseDiabetologia, 1999
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Comparative Tolerability Profiles of Oral Antidiabetic AgentsDrug Safety, 1994
- Successful Treatment of Severe Refractory Sulfonylurea-Induced Hypoglycemia With OctreotideDiabetes Care, 1993